Watch our Latest Webinar: "Unlocking the Glycoproteome: Utilizing a Robust AI/ML Based Platform for Biomarker Discovery"

Blood glycopeptide signatures associated with reduced clinical benefit of immune checkpoint inhibitor therapy are induced by cytokines that modulate expression of glycosylation-related genes in the liver

Get in touch